STOCK TITAN
  1. Home
  2. Sec-filings
  3. AGX
  4. [Form 4] ARGAN INC Insider Trading Activity

Argan Inc (NYSE: AGX) director discloses vesting of TRSUs into stock

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Argan Inc director Peter W. Getsinger reported that time-based restricted stock unit awards vested and converted into common stock in two transactions during December 2025.

The awards, originally granted in December 2022 and December 2023, followed three-year vesting schedules, after which shares of Argan common stock became issuable to him at an exercise price of $0.

After these transactions, he directly owned 12,597 shares of common stock and held 1,364 time-based restricted stock units as ongoing stock-based compensation.

Positive

  • None.

Negative

  • None.
Insider Getsinger Peter W
Role Director
Type Security Shares Price Value
Exercise Time-Based Restricted Stock Units 1,750 $0.00 --
Exercise Common Stock 1,844 $0.00 --
Exercise Time-Based Restricted Stock Units 833 $0.00 --
Exercise Common Stock 856 $0.00 --
Holdings After Transaction: Time-Based Restricted Stock Units — 1,364 shares (Direct); Common Stock — 12,597 shares (Direct)
Footnotes (1)
  1. Pursuant to the three-year vesting schedule of the Time-Based Restricted Stock Unit ("TRSU") awarded to the Reporting Person on December 14, 2023, 833 shares of common stock became issuable to the Reporting Person on December 14, 2025 and is adjusted for dividends. Pursuant to the three-year vesting schedule of the Time-Based Restricted Stock Unit ("TRSU") awarded to the Reporting Person on December 16, 2022, 1,750 shares of common stock became issuable to the Reporting Person on December 16, 2025 and is adjusted for dividends.
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Getsinger Peter W
(Last) (First) (Middle)
4075 WILSON BOULEVARD
SUITE 440
(Street)
ARLINGTON VA 22203
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
ARGAN INC [ AGX ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
12/14/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 12/14/2025 M 856(1) A $0 10,753 D
Common Stock 12/16/2025 M 1,844(2) A $0 12,597 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Time-Based Restricted Stock Units $0 12/14/2025 M 833 (1) (1) Common Stock 833 $0 3,114 D
Time-Based Restricted Stock Units $0 12/16/2025 M 1,750 (2) (2) Common Stock 1,750 $0 1,364 D
Explanation of Responses:
1. Pursuant to the three-year vesting schedule of the Time-Based Restricted Stock Unit ("TRSU") awarded to the Reporting Person on December 14, 2023, 833 shares of common stock became issuable to the Reporting Person on December 14, 2025 and is adjusted for dividends.
2. Pursuant to the three-year vesting schedule of the Time-Based Restricted Stock Unit ("TRSU") awarded to the Reporting Person on December 16, 2022, 1,750 shares of common stock became issuable to the Reporting Person on December 16, 2025 and is adjusted for dividends.
/s/ Peter W. Getsinger 12/17/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Argan Inc (AGX) report in December 2025?

An Argan Inc director reported the vesting of time-based restricted stock unit awards that converted into common stock in two transactions during December 2025.

Who is the reporting person in this Argan Inc (AGX) insider filing?

The reporting person is Peter W. Getsinger, who serves as a director of Argan Inc.

On what dates did the Argan Inc directors restricted stock units vest?

The time-based restricted stock unit awards vested in transactions dated 12/14/2025 and 12/16/2025.

What equity awards were involved in the Argan Inc (AGX) directors transactions?

The transactions involved Time-Based Restricted Stock Unit (TRSU) awards that were originally granted on 12/16/2022 and 12/14/2023.

How many Argan Inc shares and units did the director hold after the reported transactions?

Following the reported transactions, the director directly owned 12,597 shares of Argan common stock and held 1,364 time-based restricted stock units.

What was the vesting schedule for the Argan Inc directors TRSU awards?

Each Time-Based Restricted Stock Unit award followed a three-year vesting schedule, after which common shares became issuable to the director.